We are live on ! Find out more
MRM

MEDIROM Healthcare Technologies

8 hedge funds and large institutions have $176K invested in MEDIROM Healthcare Technologies in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more capital invested

Capital invested by funds: $67.8K → $176K (+$108K)

60% more funds holding

Funds holding: 58 (+3)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

1.39% more ownership

Funds ownership: 0.76%2.15% (+1.4%)

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

MRM Hedge Fund Activity: Q2 2026 in Review

8 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q2 2026, worth a combined $176K — up 160% from $67.8K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MRM positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $63K. The largest seller was Two Sigma Securities, cutting an estimated $3.83K.

  • 8 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q2 2026, up from 5 in Q1 2026.
  • Funds reported $176K of MEDIROM Healthcare Technologies stock for Q2 2026, up 160% quarter-over-quarter.
  • 3 funds opened new MEDIROM Healthcare Technologies positions in Q2 2026 and 0 closed out, a net change of +3 holders.
  • The largest MEDIROM Healthcare Technologies buyer in Q2 2026 was Citadel Advisors, an estimated $63K added.
  • The largest MEDIROM Healthcare Technologies seller in Q2 2026 was Two Sigma Securities, an estimated $3.83K sold.

Based on aggregated 13F filings for Q2 2026.